Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders
Background. Obesity is an independent risk factor of the cardiovascular complications in patients with arterial hypertension (HTN). It can directly contribute to an increase in blood pressure (BP). Thus, the treatment of patients with HTN and obesity becomes a complex clinical problem, which require...
Guardado en:
Autores principales: | Nikita B. Perepech, Irina E. Chazova, Juliya V. Zhernakova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Morozov P.V.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/787d111126704ecea8d8804d2f5761cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Full spectrum and genetic algorithm-selected spectrum-based chemometric methods for simultaneous determination of azilsartan medoxomil, chlorthalidone, and azilsartan: Development, validation, and application on commercial dosage form
por: Darwish Hany W., et al.
Publicado: (2021) -
Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus
por: Juliya V. Zhernakova, et al.
Publicado: (2021) -
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
por: Omboni S, et al.
Publicado: (2015) -
Azilsartan Suppresses Osteoclastogenesis and Ameliorates Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species Production and Activating Nrf2 Signaling
por: Bin Pan, et al.
Publicado: (2021) -
ACID- ALKALI DEGRADATION STUDY ON OLMESARTAN MEDOXOMIL AND DEVELOPMENT OF VALIDATED STABILITY-INDICATING CHROMATOGRAPHIC METHODS
por: MOUSSA,BAHIA, et al.
Publicado: (2010)